Top Markets
Coin of the day
Defence Therapeutics Inc. Defence Therapeutics Inc.

Defence Therapeutics Inc.

DTC
Clasificación en acciones #28139
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Precio por acción
$0.37430781
Última sincronización: 2026-08-19
Capitalización bursátil
$28.37M
Cambio (1 día)
2.00%
Cambio (1 año)
-13.46%
País
CA
Comercio Defence Therapeutics Inc. (DTC)

Categoría

Historial del precio de la acción de Defence Therapeutics Inc. (DTC)
Precio más alto de cierre: $0.32 el 2026-08-01

Precio más bajo de cierre: $2.94 el 2021-05-01
Historial del precio de la acción de Defence Therapeutics Inc. desde 2021 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -20.25%
2025 47.28%
2024 -78.72%
2023 11.75%
2022 -62.63%
2021 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$121.82 -14.23%
AU
$753.28 5.84%
CH